Quick Answer
X4 Pharmaceuticals, Inc reported Common Stock Shares Outstanding of 90.91 million shares for the year ending 2025.
- X4 Pharmaceuticals, Inc showed an increase of +1,495.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from X4 Pharmaceuticals, Inc's annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), X4 Pharmaceuticals, Inc's Common Stock Shares Outstanding has grown by 536.0%.
- Historical annual values: Fiscal year 2025: 90.91 million shares | Fiscal year 2024: 5.70 million shares | Fiscal year 2023: 167.43 million shares | Fiscal year 2022: 121.67 million shares | Fiscal year 2021: 28.13 million shares | Fiscal year 2020: 16.31 million shares | Fiscal year 2019: 16.13 million shares | Fiscal year 2018: 351,652 shares | Fiscal year 2017: 14.29 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: